Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shiwei Heibingpian Wan is a traditional Tibetan medicine (TTM) manufactured by Xizang Ganlu Tibetan Medicine. It is an oral pill formulation primarily indicated for the treatment of cholelithiasis (gallstones), urolithiasis (urinary stones), and various digestive disorders such as chronic gastritis and dyspepsia. The formulation is based on traditional Tibetan medical principles, utilizing a combination of mineral and herbal ingredients to promote stone dissolution and improve gastrointestinal heat. Key components typically include processed black alum, pomegranate seed, cinnamon, and other aromatic herbs. It is an approved pharmaceutical product in China, registered under the National Drug Standard for Tibetan Medicine (National Drug License Number Z54020049).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shiwei Heibingpian Wan.